New COPD inhaler shows promise in early trial

NCT ID NCT06545500

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested an inhaled medication called glycopyrrolate in 46 people with COPD. Participants received three different doses of the drug and a placebo over separate one-week periods. The goal was to see if the drug improves lung function and is safe. This is an early-stage trial to find the right dose for future studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • American Health Research Inc

    Charlotte, North Carolina, 28277, United States

  • Clinical Research of West Florida Inc - Clearwater

    Clearwater, Florida, 33765, United States

  • Clinical Research of West Florida Inc - Tampa

    Tampa, Florida, 33606, United States

  • Midwest Chest Consultants PC

    Saint Charles, Missouri, 63301, United States

  • Velocity Clinical Research - Greenville

    Greenville, South Carolina, 29615, United States

  • Velocity Clinical Research - Spartanburg

    Spartanburg, South Carolina, 29303, United States

  • Velocity Clinical Research - Union

    Union, South Carolina, 29379, United States